Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,541.7
41.9 (1.68%)

 

  • STI Straits Times Index
    2,541.7
    41.9 (1.68%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,436.8
    -15.3 (-1.06%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,465.6
    513.4 (2.24%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,845.7
    27.7 (0.98%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,271.2
    529.5 (2.55%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,625.1
    79.1 (1.74%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 682.6M
  • Value: 829.2M
  • Rise: 233
  • Fall: 79
  • Unch: 496

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Medtecs Intl0.194+0.017
Rex Intl0.144+0.007
Broadway Ind^0.101+0.008
ThaiBev0.650+0.010
Mapletree Log Tr1.860+0.030
Secura0.075+0.008
CapitaMall Trust1.890+0.040
Suntec Reit1.450+0.080
Singtel2.670+0.030
CapitaCom Trust1.630+0.010

World Indices

World Indices
Name Last Change
Nasdaq 9,324.6 +39.7
HSI 23,446.3 +494.1
HSCEI 9,632.6 +166.6
Jakarta 4,625.5 +79.6
Nikkei 225 21,271.2 +529.5
SSE Comp 2,845.5 +27.5
Shanghai A 2,982.5 +28.8
Shanghai B 207.9 +3.8
KOSPI 2,029.8 +35.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

AETERNA ZENTARIS INC AETERNA ZENTARIS
Updated on 22 May 2020 (End of trading day)
Last (USD): 1.089 Change: -0.056 High: 1.140 Remarks: -
Change (%): -4.88 Low: 1.020
Open 1.080 Yesterday's Close 1.145
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 408,085 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.25740 Trailing EPS (USD) e -0.01500 NAV (USD) b 0.0719
PE a - Trailing PE f - Price / NAV b 15.1474
Dividend (USD) d - Cash In Hand (USD) g 0.3912 Issued & Paid-up Shares c 23,472,800
Dividend Yield (%) d - Price / Cash In Hand g 2.784 Treasury Shares h -
Beta - 75 Daysi 1.085 R-Squared - 75 Days(%)i 14.14 Market Cap (M) 25.564
Beta - 500 Daysi 0.660 R-Squared - 500 Days (%)i 2.85 Enterprise Value (M) 16.742
Piotroski F Score 0 Exchange Code AEZS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 115.04 Free Float (%) 100.0
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 02 Apr 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 20 Nov 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference AETERNA ZENTARIS INC NASDAQ 25.564 - - 15.1474 -
Industry Biotechnology NASDAQ 2,772.137 361.669 68678.556 6.8161 0.692
Local Peer AMGEN INC NASDAQ 133,196.768 16.985 17.355 14.0429 2.575
Local Peer GILEAD SCIENCES INC NASDAQ 91,968.360 17.075 18.535 4.1677 3.469
Local Peer VERTEX PHARMACEUTICAL NASDAQ 73,883.574 62.783 48.899 11.4342 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 64,127.396 30.309 28.135 5.2854 -
Local Peer ILLUMINA INC NASDAQ 52,140.900 52.037 55.351 11.2494 -
Local Peer BIOGEN INC NASDAQ 49,695.337 8.439 8.453 3.9608 -
Local Peer SEATTLE GENETICS INC NASDAQ 26,964.099 - - 15.2717 -
Local Peer MODERNA INC NASDAQ 25,614.456 - - 15.6102 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,413.941 9.322 9.441 1.9079 -
Local Peer INCYTE CORPORATION NASDAQ 21,600.355 48.333 - 11.1473 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 17,633.416 - 154.671 5.4425 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 15,888.877 - - 11.7719 -
Other Local Peers GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), UNIQURE N.V. (NASDAQ), TG THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), NOVAVAX INC (NASDAQ), ALECTOR INC (NASDAQ), INSMED INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), EPIZYME INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), EDITAS MEDICINE INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), REGENXBIO INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CYTOKINETICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), VERACYTE INC (NASDAQ), MACROGENICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), COMPUGEN (NASDAQ), PASSAGE BIO INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), NEXTCURE INC (NASDAQ), IMMUNOGEN INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), RETROPHIN INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ARDELYX INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), AVROBIO INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), NANTKWEST INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), PROTHENA CORP PLC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), MERUS B V (NASDAQ), PRECIGEN INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), XBIOTECH INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), PERSONALIS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), PDL BIOPHARMA INC (NASDAQ), KAMADA (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CHIASMA INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), VERMILLION INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), XOMA CORP (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), AFFIMED N V (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), VAXART INC (NASDAQ), INFLARX N V (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), IMV INC (NASDAQ), IVERIC BIO INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), ARAVIVE INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), SAVARA INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), LUMOS PHARMA INC (NASDAQ), COHBAR INC (NASDAQ), RECRO PHARMA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), RESTORBIO INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), SYNLOGIC INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), INMUNE BIO INC (NASDAQ), VACCINEX INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), EQUILLIUM INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ADVAXIS INC (NASDAQ), ZAFGEN INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ATYR PHARMA INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), TOCAGEN INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CURIS INC (NASDAQ), EVOGENE LTD (NASDAQ), BIOCARDIA INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), PRECIPIO INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ)
Global Peer CSL ASX 135,429.195 50.478 46.751 15.6594 0.889
Global Peer AMGEN-T HKEx 588,247.000 9.574 9.804 8.0015 4.569
Global Peer AGILENT TECHNOLOGIES INC NYSE 26,314.142 24.570 38.527 5.5189 0.771
Global Peer WUXI BIO HKEx 166,757.175 145.061 145.060 11.6609 -
Global Peer SINO BIOPHARM HKEx 151,287.045 49.290 49.291 4.3472 0.663
Global Peer BEIGENE HKEx 98,351.659 - - 4.5121 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 4,434.868 81.374 65.123 4.1262 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer GENSCRIPT BIO HKEx 31,823.600 - - 10.6694 -
Global Peer 3SBIO HKEx 23,176.505 20.991 20.991 2.1526 -
Other Global Peers ALPHAMAB-B (HKEx), ARCUS BIOSCIENCES INC (NYSE), VIVA BIOTECH (HKEx), MESOBLAST LTD (ASX), HAOHAI BIOTEC (HKEx), MYOVANT SCIENCES LTD (NYSE), POLYNOVO LIMITED (ASX), FRONTAGE (HKEx), KINTOR PHARMA-B (HKEx), KADMON HLDGS INC (NYSE), ASCENTAGE-B (HKEx), AVITA MEDICAL LTD (ASX), SINOMAB BIO-B (HKEx), NANOVIRICIDES INC (NYSE American), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), LEE'S PHARM (HKEx), DPHARMA (Bursa), BBI LIFE SCI (HKEx), TELIX PHARMACEUTIC (ASX), NEXT SCIENCE LTD (ASX), PFENEX INC (NYSE American), ENZO BIOCHEM INC (NYSE), IBIO INC (NYSE American), CEL-SCI CORP (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), UNI-BIO GROUP (HKEx), NEUREN PHARMACEUTICALS LTD (ASX), IMUGENE LIMITED (ASX), 22ND CENTURY GROUP INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), IMMUTEP LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), BIOTRON (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CT ENTERPRISE (HKEx), MEMPHASYS LTD (ASX), BIOSINO BIO-TEC (HKEx), ORAGENICS INC (NYSE American), ANTEOTECH LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), KAZIA THERAPEUTICS LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), CCP TECHNOLOGIES LTD (ASX), Suntar Eco-City^ (SGX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), BIONOMICS LTD (ASX), REGENT PACIFIC (HKEx), ACTINIUM PHARMACEUTICALS INC (NYSE American), SIENNA CANCER DIAGNOSTICS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), REGENEUS LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), RHINOMED LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), PATRYS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ADALTA LTD (ASX), HAO WEN HLDGS (HKEx), ANATARA LIFESCIENCES LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), LEAF RESOURCES LTD (ASX), CRYOSITE (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.134
+14.04 %
10 Days -+0.079
+7.83 %
20 Days -+0.294
+36.99 %
Medium Term Return 3 Months -+0.169
+18.38 %
6 Months -+0.204
+23.06 %
1 Year --2.061
-65.43 %
Long Term Return 2 Years --1.351
-55.36 %
3 Years --0.001
-0.08 %
5 Years --28.561
-96.33 %
Annualised Return Annualised --
-48.36 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.396 - 3.220 Change From 1 Year Low +0.693 % Change From 1 Year Low (%) +174.89
Change From 1 Year High -2.131 % Change From 1 Year High (%) -66.18
2 Years Range 0.396 - 5.570 Change From 2 Years Low +0.693 % Change From 2 Years Low (%) +174.89
Change From 2 Years High -4.481 % Change From 2 Years High (%) -80.45
5 Years Range 0.396 - 31.380 Change From 5 Years Low +0.693 % Change From 5 Years Low (%) +174.89
Change From 5 Years High -30.291 % Change From 5 Years High (%) -96.53
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.

Historical Price Data

Date Open High Low Close Volume VWAP
22 May 2020 1.080 1.140 1.020 1.089 408,085 -
21 May 2020 0.950 1.250 0.950 1.145 1,442,832 -
20 May 2020 0.947 0.970 0.947 0.950 147,289 -
19 May 2020 0.939 0.960 0.912 0.955 182,724 -
18 May 2020 0.925 0.960 0.905 0.930 153,068 -
15 May 2020 0.990 1.000 0.912 0.930 137,557 -
14 May 2020 0.930 0.990 0.911 0.969 75,061 -
13 May 2020 1.000 1.010 0.910 0.954 275,059 -
12 May 2020 1.030 1.050 0.990 1.010 251,219 -
11 May 2020 1.100 1.100 0.990 1.050 321,134 -
08 May 2020 1.110 1.119 1.030 1.050 338,337 -
07 May 2020 1.020 1.110 0.880 1.100 1,337,297 -
06 May 2020 0.850 1.250 0.812 1.010 6,120,548 -
05 May 2020 0.750 0.770 0.750 0.768 135,340 -
04 May 2020 0.735 0.735 0.719 0.730 43,073 -
01 May 2020 0.731 0.766 0.731 0.735 55,792 -
30 Apr 2020 0.790 0.820 0.710 0.770 108,016 -
29 Apr 2020 0.790 0.820 0.772 0.810 172,832 -
28 Apr 2020 0.824 0.830 0.781 0.795 73,517 -
27 Apr 2020 0.780 0.830 0.780 0.817 73,197 -
24 Apr 2020 0.800 0.800 0.770 0.788 103,919 -
23 Apr 2020 0.760 0.800 0.760 0.800 43,518 -
Summary
Current 2 Weeks
(11 May 2020 to 22 May 2020)
1.100 1.250 0.905 1.089 3,394,028 -
Previous 2 Weeks
(27 Apr 2020 to 08 May 2020)
0.780 1.250 0.780 1.050 8,457,949 -
4 Weeks from
(27 Mar 2020 to 24 Apr 2020)
0.520 1.250 0.480 0.788 6,771,923 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.